Structure Therapeutics Inc.
GPCR
$19.61
$0.241.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.66M | -46.83M | -36.48M | -33.98M | -26.03M |
| Total Depreciation and Amortization | 291.00K | 274.00K | 266.00K | 276.00K | 232.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.73M | 1.13M | 280.00K | 302.00K | 1.44M |
| Change in Net Operating Assets | 3.08M | -6.80M | -534.00K | 13.70M | -2.03M |
| Cash from Operations | -54.56M | -52.23M | -36.47M | -19.70M | -26.39M |
| Capital Expenditure | -232.00K | -314.00K | -16.00K | -685.00K | -427.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 49.17M | 34.35M | 33.25M | -188.36M | -204.09M |
| Cash from Investing | 48.94M | 34.03M | 33.23M | -189.04M | -204.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 517.00K | 965.00K | 615.00K | 397.00K | 515.29M |
| Repurchase of Common Stock | 0.00 | -156.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -1.15M | -589.00K |
| Cash from Financing | 517.00K | 809.00K | 615.00K | -757.00K | 514.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.10M | -17.39M | -2.62M | -209.50M | 283.80M |